Fangping Xu

1.3k total citations
52 papers, 847 citations indexed

About

Fangping Xu is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Fangping Xu has authored 52 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 15 papers in Molecular Biology and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Fangping Xu's work include HER2/EGFR in Cancer Research (13 papers), Lymphoma Diagnosis and Treatment (8 papers) and Breast Cancer Treatment Studies (7 papers). Fangping Xu is often cited by papers focused on HER2/EGFR in Cancer Research (13 papers), Lymphoma Diagnosis and Treatment (8 papers) and Breast Cancer Treatment Studies (7 papers). Fangping Xu collaborates with scholars based in China, United States and Hong Kong. Fangping Xu's co-authors include Jiandong Luo, Yanzhen Wang, Minsheng Chen, Yan‐Hui Liu, Alex F. Chen, Yi Quan, Xin-lan Luo, Jie Xu, Donglan Luo and Jiong Bi and has published in prestigious journals such as Circulation, Cancer Research and Nutrients.

In The Last Decade

Fangping Xu

48 papers receiving 832 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangping Xu China 16 312 235 219 129 123 52 847
Nobuhide Hayashi Japan 12 423 1.4× 127 0.5× 144 0.7× 77 0.6× 102 0.8× 42 1.0k
Dae Hyun Song South Korea 19 465 1.5× 193 0.8× 195 0.9× 97 0.8× 90 0.7× 90 1.1k
Yunhe Liu China 19 438 1.4× 246 1.0× 164 0.7× 57 0.4× 85 0.7× 51 1.1k
Shiraj Sen United States 16 544 1.7× 198 0.8× 129 0.6× 165 1.3× 101 0.8× 57 1.1k
Malin Dahlgren Sweden 7 317 1.0× 226 1.0× 385 1.8× 100 0.8× 383 3.1× 10 1.1k
Steven D. Trocha United States 18 240 0.8× 310 1.3× 141 0.6× 73 0.6× 229 1.9× 43 1.1k
J.S.P. Yuen Singapore 15 481 1.5× 199 0.8× 242 1.1× 129 1.0× 52 0.4× 38 1.1k
Antonella Verrienti Italy 24 652 2.1× 310 1.3× 287 1.3× 92 0.7× 104 0.8× 74 1.8k
Nicolas Dif France 7 319 1.0× 188 0.8× 290 1.3× 89 0.7× 136 1.1× 8 771

Countries citing papers authored by Fangping Xu

Since Specialization
Citations

This map shows the geographic impact of Fangping Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangping Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangping Xu more than expected).

Fields of papers citing papers by Fangping Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangping Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangping Xu. The network helps show where Fangping Xu may publish in the future.

Co-authorship network of co-authors of Fangping Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Fangping Xu. A scholar is included among the top collaborators of Fangping Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangping Xu. Fangping Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiu, Zhen‐Bin, Hongji Li, Chao Zhang, et al.. (2025). Quantifying Early-Stage Lung Adenocarcinoma Progression with a Radiomic Trajectory. npj Digital Medicine. 8(1). 664–664.
2.
Liu, Meng, et al.. (2025). A two‐level optimal scheduling control strategy for air source heat pump loads with phase change energy storage. IET Generation Transmission & Distribution. 19(1). 2 indexed citations
3.
4.
Xu, Fangping, et al.. (2024). Feasibility of intraoperative assessment of STAS in pathologic stage 1 lung adenocarcinomas in Chinese patients. European Journal of Surgical Oncology. 51(8). 108747–108747. 2 indexed citations
5.
6.
Liu, Lin, et al.. (2022). MRI findings of benign tumors and tumor-like diseases of the tongue with radiologic–pathologic correlation. Japanese Journal of Radiology. 41(1). 19–26. 3 indexed citations
7.
Chen, Yu, Zhi Xie, Jie Jiang, et al.. (2021). High SHP2 expression determines the efficacy of PD‐1/PD‐L1 inhibitors in advanced KRAS mutant non‐small cell lung cancer. Thoracic Cancer. 12(19). 2564–2573. 9 indexed citations
8.
Ding, Ye, Ping Hu, Ye Mei, et al.. (2021). Reproducibility and relative validity of a semi-quantitative food frequency questionnaire for the Chinese lactating mothers. Nutrition Journal. 20(1). 20–20. 11 indexed citations
9.
Liao, Chengcheng, et al.. (2021). Changes in Protein Glycosylation in Head and Neck Squamous Cell Carcinoma. Journal of Cancer. 12(5). 1455–1466. 26 indexed citations
10.
11.
Xu, Fangping, Kun Wang, Jie Xu, et al.. (2017). Impact of repeat HER2 testing after initial equivocal HER2 FISH results using 2013 ASCO/CAP guidelines. Breast Cancer Research and Treatment. 166(3). 757–764. 6 indexed citations
12.
Zhong, Wen‐Zhao, Jian Su, Fangping Xu, et al.. (2015). Rare discrepancies in a driver gene alteration within histologically heterogeneous primary lung cancers. Lung Cancer. 90(2). 205–211. 6 indexed citations
13.
Yan, Li‐Xu, Yan‐Hui Liu, Jianwen Xiang, et al.. (2015). PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer. International Journal of Oncology. 48(2). 471–484. 97 indexed citations
14.
15.
Xu, Fangping, Yan‐Hui Liu, Donglan Luo, et al.. (2011). [Clinicopathological features of Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly].. PubMed. 40(9). 616–21. 3 indexed citations
16.
Luo, Donglan, Yan‐Hui Liu, Li Li, et al.. (2011). [Immunophenotypes and prognosis of diffuse large B-cell lymphoma: a study of 500 cases].. PubMed. 40(4). 235–9. 3 indexed citations
17.
Wu, Hongmei, Yan‐Hui Liu, Lin Feng, et al.. (2011). [Association of HER2 protein expression with clinicopathologic features and prognosis in Chinese patients with gastric carcinoma].. PubMed. 40(5). 296–9. 10 indexed citations
18.
Liu, Yan‐Hui, Fangping Xu, Ning Liao, et al.. (2010). Efficacy of intraoperative GeneSearch Breast Lymph Node (BLN) Assay for breast cancer metastasis detection in sentinel lymph node in Chinese patients. Cancer Science. 101(8). 1920–1924. 7 indexed citations
19.
Zhang, Meng, et al.. (2006). Promoter Hypermethylation of a Novel Gene, ZHX2, in Hepatocellular Carcinoma. American Journal of Clinical Pathology. 125(5). 740–746. 47 indexed citations
20.
Xu, Fangping, et al.. (2006). Simvastatin inhibits leptin-induced hypertrophy in cultured neonatal rat cardiomyocytes1. Acta Pharmacologica Sinica. 27(4). 419–422. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nobuhide Hayashi Breakdown of academic impact, for papers by Dae Hyun Song Breakdown of academic impact, for papers by Yunhe Liu Breakdown of academic impact, for papers by Shiraj Sen Breakdown of academic impact, for papers by Malin Dahlgren Breakdown of academic impact, for papers by Steven D. Trocha Breakdown of academic impact, for papers by J.S.P. Yuen Breakdown of academic impact, for papers by Antonella Verrienti Breakdown of academic impact, for papers by Nicolas Dif
Rankless by CCL
2026